Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 24Terminated 7Recruiting 3Unknown 2Active not recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 1Gastrointestinal Neoplasms 1Cancer Pain 1Adult Patients Who Are Receiving Oncologic Care 1Adjustment Disorders 1

Interventions

Specimen Handling 336Magnetic Resonance Spectroscopy 333Radiotherapy 315Cyclophosphamide 295pembrolizumab 282Cisplatin 266Carboplatin 245Drug Therapy 237Blood Specimen Collection 233Biopsy 206Bevacizumab 187Gemcitabine 177venetoclax 172Radiosurgery 169Capecitabine 165Oxaliplatin 163fludarabine 160Nivolumab 156Paclitaxel 155Standard of Care 137Surveys and Questionnaires 131Surgical Procedures, Operative 130Dexamethasone 127Fluorouracil 125Docetaxel 113tislelizumab 110Rituximab 110Cytarabine 104atezolizumab 101Azacitidine 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × OTHER × Pharmacogenomic Testing × Clear all
NCT06511401 2026-05-04

C-PAIN

University of Chicago

Phase NA Recruiting
800 enrolled

Adult Patients Who Are Receiving Oncologic Care

NCT06489041 2026-02-02

Evaluating Microarray Pharmacogenetic Testing in Cancer Patients

Wake Forest University Health Sciences

Phase NA Recruiting
120 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

NCT05830279 2025-07-09

Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Recruiting
600 enrolled

Cancer Pain, Adjustment Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡